Prospectus Publication Announcement
OKYO Pharma Limited (OKYO.L) Positive Data in an Animal Model using OK-201
OKYO Pharma Announces Positive Data and Results in an Animal Model using Topically Administered OK-201 to Treat Neuropathic Ocular Pain
Tiziana Life Sci PLC (TILS.L) B. Riley Virtual Neuroscience Investor Conference
Tiziana Life Sciences to participate in a Fireside Chat on 28 April 2021 at 10:30 a.m. EDT
Tiziana Life Sci PLC (TILS.L) Announces Plans to List Accustem Sciences Limited in the U.S.
NEW YORK and LONDON, April 13, 2021 – Tiziana Life Sciences plc (NASDAQ: TLSA; LSE: TILS), today announced that its former subsidiary, Accustem Sciences Limited (“Accustem”), intends to file a
Tiziana Life Sci PLC (TILS.L) P2 Study in Moderate to Severe Covid-19 Patients
Tiziana Plans Phase 2 Clinical Study in Moderate to Severe Covid-19 Patients with Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody
OKYO Pharma Limited (OKYO.L) Appointment of Chief Scientific Officer
OKYO announces the appointment of Dr Rajkumar Patil as Chief Scientific Officer
Tiziana Life Sciences plc (TILS.L) Chairman of Tiziana to give interview on Bloomberg
Gabriele Cerrone, Chairman of Tiziana Life Sciences, to give an interview on Bloomberg Television US at 1:20 PM ET Today
Tiziana Life Sci PLC (TILS.L) Tiziana Interview to Air on Bloomberg TV
Tiziana Life Sciences Interview to Air on Bloomberg Television US on the RedChip Money Report
OKYO Pharma Limited (OKYO.L) Patent for treating Ocular Pain and Inflammation
OKYO Pharma has U.S. Patent Issued Covering its Lipid Conjugated Peptide Analogues for treating Ocular Pain and Inflammation
Tiziana Life Sci PLC (TILS.L) Tiziana at BIO CEO & Investor Digital Conference
Tiziana Life Sciences to Present at the BIO CEO & Investor Digital Conference
Tiziana Life Sci PLC (TILS.L) Appointment of Dr Thomas Adams, Ph.D. as an executive director
NEW YORK and LONDON – February 5, 2021 (GLOBE NEWSWIRE) – Tiziana Life Sciences plc (NASDAQ: TLSA / LSE: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative
Tiziana Life Sci PLC (TILS.L) CEO exclusive interview to discuss COVID-19 Trial
Tiziana Life Sciences CEO Discusses COVID-19 Trial Data in Exclusive Interview